Kılıçkap, SaadettinÖlmez, Ömer FatihCicin, İrfanDemirci, UmutAlan, O.Çabuk, DevrimSakalar, TeomanTatlı, Ali MuratBuğdaycı, F. BaşolEralp, YeşimUysal, MükreminDemirkazik, AhmetBilgin, BurakYıldız, BirolKaraağaç, MustafaOkutur, KeremSakin, Ayşegül10.07.20192019-07-1010.07.20192019-07-102018Kılıçkap, S., Ölmez, Ö. F., Cicin, İ., Demirci, U., Alan, O., Çabuk, D. ... Sakin, A. (2018). The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey. 43rd ESMO Congress (ESMO) içinde (505-505. ss.). Munich, Germany, October 19-23, 2018.0923-75341569-8041https://hdl.handle.net/20.500.12511/187743rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANYWOS: 000459277303171[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessConference Object29Supplement: 8505505Q1